These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K. BMC Infect Dis; 2017 Apr 17; 17(1):280. PubMed ID: 28415989 [Abstract] [Full Text] [Related]
4. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Skenders GK, Holtz TH, Riekstina V, Leimane V. Int J Tuberc Lung Dis; 2011 Nov 17; 15(11):1546-52, i. PubMed ID: 22008771 [Abstract] [Full Text] [Related]
6. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Jin J, Zhang Y, Fan X, Diao N, Shao L, Wang F, Hu P, Wang S, Weng X, Zhang W. Int J Tuberc Lung Dis; 2012 Apr 17; 16(4):521-6. PubMed ID: 22325117 [Abstract] [Full Text] [Related]
7. Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda. Bwanga F, Joloba ML, Haile M, Hoffner S. Int J Tuberc Lung Dis; 2010 Jul 17; 14(7):890-5. PubMed ID: 20550774 [Abstract] [Full Text] [Related]
8. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories. Int J Tuberc Lung Dis; 2002 Sep 17; 6(9):748-56. PubMed ID: 12234129 [Abstract] [Full Text] [Related]
13. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia. Bedewi Omer Z, Mekonnen Y, Worku A, Zewde A, Medhin G, Mohammed T, Pieper R, Ameni G. Int J Mycobacteriol; 2016 Dec 17; 5(4):475-481. PubMed ID: 27931690 [Abstract] [Full Text] [Related]
14. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Guo Y, Zhou Y, Wang C, Zhu L, Wang S, Li Q, Jiang G, Zhao B, Huang H, Yu H, Xing W, Mitchelson K, Cheng J, Zhao Y. Int J Tuberc Lung Dis; 2009 Jul 17; 13(7):914-20. PubMed ID: 19555544 [Abstract] [Full Text] [Related]
17. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates. Nimri L, Samara H, Batchoun R. FEMS Immunol Med Microbiol; 2011 Aug 17; 62(3):321-7. PubMed ID: 21569121 [Abstract] [Full Text] [Related]
18. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Am J Respir Crit Care Med; 2008 Apr 01; 177(7):787-92. PubMed ID: 18202343 [Abstract] [Full Text] [Related]
19. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia. Moga S, Bobosha K, Fikadu D, Zerihun B, Diriba G, Amare M, Kempker RR, Blumberg HM, Abebe T. PLoS One; 2023 Apr 01; 18(4):e0284737. PubMed ID: 37099514 [Abstract] [Full Text] [Related]
20. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh. Ahmed S, Shukla I, Fatima N, Varshney SK, Shameem M. Indian J Med Microbiol; 2017 Apr 01; 35(4):568-574. PubMed ID: 29405151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]